Keylika focuses on the intersection of drug discovery and drug delivery, employing AI-enabled de novo drug design and nanotechnology-based transdermal delivery technologies to develop breakthrough therapies, including the world's first Rx skin patch for treating iron deficiency anemia
Keylika focuses on the intersection of drug discovery and drug delivery, employing AI-enabled de novo drug design and nanotechnology-based transdermal delivery technologies to develop breakthrough therapies, including the world's first Rx skin patch for treating iron deficiency anemia.